Correlation Between Assembly Biosciences and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assembly Biosciences and Lyra Therapeutics, you can compare the effects of market volatilities on Assembly Biosciences and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and Lyra Therapeutics.
Diversification Opportunities for Assembly Biosciences and Lyra Therapeutics
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Assembly and Lyra is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Assembly Biosciences and Lyra Therapeutics
Given the investment horizon of 90 days Assembly Biosciences is expected to generate 0.41 times more return on investment than Lyra Therapeutics. However, Assembly Biosciences is 2.41 times less risky than Lyra Therapeutics. It trades about 0.4 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.46 per unit of risk. If you would invest 1,285 in Assembly Biosciences on March 7, 2024 and sell it today you would earn a total of 225.00 from holding Assembly Biosciences or generate 17.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Assembly Biosciences vs. Lyra Therapeutics
Performance |
Timeline |
Assembly Biosciences |
Lyra Therapeutics |
Assembly Biosciences and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Assembly Biosciences and Lyra Therapeutics
The main advantage of trading using opposite Assembly Biosciences and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.Assembly Biosciences vs. Akari Therapeutics PLC | Assembly Biosciences vs. Artelo Biosciences | Assembly Biosciences vs. Nutriband | Assembly Biosciences vs. Aileron Therapeutics |
Lyra Therapeutics vs. Monte Rosa Therapeutics | Lyra Therapeutics vs. Design Therapeutics | Lyra Therapeutics vs. Werewolf Therapeutics | Lyra Therapeutics vs. Ikena Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |